ABSTRACT
This study combined the herbal pair Platycodonis Radix-Curcumae Rhizoma(PR-CR) possessing an inhibitory effect on tumor cell proliferation and metastasis with the active component of traditional Chinese medicine(TCM) silibinin-loaded nanoparticles(NPs) with a regulatory effect on tumor microenvironment based on the joint effect on tumor cells and tumor microenvironment to inhi-bit cell metastasis. The effects of PR-CR on the cellular uptake of NPs and in vitro inhibition against breast cancer proliferation and metastasis were investigated to provide an experimental basis for improving nanoparticle absorption and enhancing therapeutic effects. Silibinin-loaded lipid-polymer nanoparticles(LPNs) were prepared by the nanoprecipitation method and characterized by transmission electron microscopy. The NPs were spherical or quasi-spherical in shape with obvious core-shell structure. The mean particle size was 107.4 nm, Zeta potential was-27.53 mV. The cellular uptake assay was performed by in vitro Caco-2/E12 coculture cell model and confocal laser scanning microscopy(CLSM), and the results indicated that PR-CR could promote the uptake of NPs. Further, in situ intestinal absorption assay by the CLSM vertical scanning approach showed that PR-CR could promote the absorption of NPs in the enterocytes of mice. The inhibitory effect of NPs on the proliferation and migration of 4T1 cells was analyzed using 4T1 breast cancer cells and co-cultured 4T1/WML2 cells, respectively. The results of the CCK8 assay showed that PR-CR-containing NPs could enhance the inhibition against the proliferation of 4T1 breast cancer cells. The wound healing assay indicated that PR-CR-containing NPs enhanced the inhibition against the migration of 4T1 breast cancer cells. This study enriches the research on oral absorption of TCM NPs and also provides a new idea for utilizing the advantages of TCM to inhibit breast cancer metastasis.
Subject(s)
Humans , Mice , Animals , Female , Silymarin/therapeutic use , Caco-2 Cells , Polymers/chemistry , Nanoparticles/chemistry , Cell Line, Tumor , Breast Neoplasms/pathology , Tumor MicroenvironmentABSTRACT
OBJECTIVE@#To investigate the mechanism by which fibroblasts with high WNT2b expression causes intestinal mucosa barrier disruption and promote the progression of inflammatory bowel disease (IBD).@*METHODS@#Caco-2 cells were treated with 20% fibroblast conditioned medium or co-cultured with fibroblasts highly expressing WNT2b, with the cells without treatment with the conditioned medium and cells co-cultured with wild-type fibroblasts as the control groups. The changes in barrier permeability of Caco-2 cells were assessed by measuring transmembrane resistance and Lucifer Yellow permeability. In Caco-2 cells co-cultured with WNT2b-overexpressing or control intestinal fibroblasts, nuclear entry of β-catenin was detected with immunofluorescence assay, and the expressions of tight junction proteins ZO-1 and E-cadherin were detected with Western blotting. In a C57 mouse model of dextran sulfate sodium (DSS)-induced IBD-like enteritis, the therapeutic effect of intraperitoneal injection of salinomycin (5 mg/kg, an inhibitor of WNT/β-catenin signaling pathway) was evaluated by observing the changes in intestinal inflammation and detecting the expressions of tight junction proteins.@*RESULTS@#In the coculture system, WNT2b overexpression in the fibroblasts significantly promoted nuclear entry of β-catenin (P < 0.01) and decreased the expressions of tight junction proteins in Caco-2 cells; knockdown of FZD4 expression in Caco-2 cells obviously reversed this effect. In DSS-treated mice, salinomycin treatment significantly reduced intestinal inflammation and increased the expressions of tight junction proteins in the intestinal mucosa.@*CONCLUSION@#Intestinal fibroblasts overexpressing WNT2b causes impairment of intestinal mucosal barrier function and can be a potential target for treatment of IBD.
Subject(s)
Humans , Mice , Animals , Caco-2 Cells , beta Catenin/metabolism , Culture Media, Conditioned/pharmacology , Tight Junctions/metabolism , Intestinal Mucosa , Inflammatory Bowel Diseases , Tight Junction Proteins/metabolism , Inflammation/metabolism , Fibroblasts/metabolism , Mice, Inbred C57BL , Glycoproteins/metabolism , Wnt Proteins/pharmacology , Frizzled Receptors/metabolismABSTRACT
OBJECTIVE@#To investigate the mechanism by which conditioned medium of colorectal cancer cells promotes the formation of cancer-associated fibroblasts (CAFs).@*METHODS@#Normal human colorectal fibroblasts (CCD-18Co cells) in logarithmic growth phase were treated with the conditioned media of colorectal cancer HCT116 cells (HCT116-CM) or Caco-2 cells (Caco-2-CM) alone or in combination with 300 nmol/L ERK inhibitor SCH772984. The expression levels of CAFs-related molecular markers were detected in the treated cells with real-time quantitative PCR (RT- qPCR) and immunofluorescence assay, and the changes in cell proliferation, colony formation and migration were assessed with RTCA, colony formation and wound healing assays; Western blotting was performed to detect the activated signaling pathways in the fibroblasts and the changes in CAFs formation after blocking of the signaling pathway.@*RESULTS@#HCT116-CM and Caco-2-CM significantly upregulated mRNA expression levels of CAFs markers (including α-SMA, FAP, FN and TGF-β) in CCD-18Co cells, and strongly promoted fibroblast transformation into CAFs (P < 0.05). The two conditioned media also promoted the proliferation, colony formation and migration of CCD-18Co cells (P < 0.05) and significantly increased the levels of α-SMA protein and ERK phosphorylation in the cells (P < 0.05). The ERK inhibitor SCH772984 obviously inhibited the expression of α-SMA and the transformation of CCD-18Co cells into CAFs induced by the conditioned medium of colorectal cancer cells (P < 0.05).@*CONCLUSION@#Colorectal cancer cells may induce the formation of colorectal CAFs by activating the ERK pathway in the fibroblasts.
Subject(s)
Humans , Cancer-Associated Fibroblasts/metabolism , Culture Media, Conditioned/pharmacology , MAP Kinase Signaling System , Caco-2 Cells , Fibroblasts , Signal Transduction , Cell Proliferation , Cell Line, Tumor , Colorectal Neoplasms/genetics , Cell MovementABSTRACT
OBJECTIVE@#To explore the proliferation inhibitory effect of quinones from Blaps rynchopetera defense secretion on colorectal tumor cell lines.@*METHODS@#Human colorectal cancer cell HT-29, human colorectal adenocarcinoma cell Caco-2 and normal human colon epithelial cell CCD841 were chosen for the evaluation of inhibitory activity of the main quinones of B. rynchopetera defense secretion, including methyl p-benzoquinone (MBQ), ethyl p-benzoquinone (EBQ), and methyl hydroquinone (MHQ), through methyl thiazolyl tetrazolium assay. The tumor-related factors, cell cycles, related gene expressions and protein levels were detected by enzyme-linked immunosorbent assy, flow cytometry, RT-polymerase chain reaction and Western blot, respectively.@*RESULTS@#MBQ, EBQ, and MHQ could significantly inhibit the proliferation of Caco-2, with half maximal inhibitory concentration (IC50) values of 7.04 ± 0.88, 10.92 ± 0.32, 9.35 ± 0.83, HT-29, with IC50 values of 14.90 ± 2.71, 20.50 ± 6.37, 13.90 ± 1.30, and CCD841, with IC50 values of 11.40 ± 0.68, 7.02 ± 0.44 and 7.83 ± 0.05 µg/mL, respectively. Tested quinones can reduce the expression of tumor-related factors tumor necrosis factor α, interleukin (IL)-10, and IL-6 in HT-29 cells, selectively promote apoptosis, and regulate the cell cycle which can reduce the proportion of cells in the G1 phase and increase the proportion of the S phase. Meanwhile, tested quinones could up-regulate mRNA and protein expression of GSK-3β and APC, while down-regulate that of β-catenin, Frizzled1, c-Myc, and CyclinD1 in the Wnt/β-catenin pathway of HT-29 cells.@*CONCLUSION@#Quinones from B. rynchopetera defense secretion could inhibit the proliferation of colorectal tumor cells and reduce the expression of related factors, which would be functioned by regulating cell cycle, selectively promoting apoptosis, and affecting Wnt/β-catenin pathway-related mRNA and protein expressions.
Subject(s)
Humans , beta Catenin/metabolism , Caco-2 Cells , Quinones/pharmacology , Glycogen Synthase Kinase 3 beta/metabolism , Cell Proliferation , Colorectal Neoplasms/metabolism , Cell Line, Tumor , Apoptosis , Benzoquinones/pharmacology , RNA, Messenger , Wnt Signaling PathwayABSTRACT
OBJECTIVES@#Hypoxia can alter the oral bioavailability of drugs, including various substrates (drugs) of P-glycoprotein (P-gp), suggesting that hypoxia may affect the function of P-gp in intestinal epithelial cells. Currently, Caco-2 monolayer model is the classic model for studying the function of intestinal epithelial P-gp. This study combines the Caco-2 monolayer model with hypoxia to investigate the effects of hypoxia on the expression and function of P-gp in Caco-2 cells, which helps to elucidate the mechanism of changes in drug transport on intestinal epithelial cells in high-altitude hypoxia environment.@*METHODS@#Normally cultured Caco-2 cells were cultured in 1% oxygen concentration for 24, 48, and 72 h, respectively. After the extraction of the membrane proteins, the levels of P-gp were measured by Western blotting. The hypoxia time, with the most significant change of P-gp expression, was selected as the subsequent study condition. After culturing Caco-2 cells in transwell cells for 21 days and establishing a Caco-2 monolayer model, they were divided into a normoxic control group and a hypoxic group. The normoxic control group was continuously cultured in normal condition for 72 h, while the hypoxic group was incubated for 72 h in 1% oxygen concentration. The integrity and polarability of Caco-2 cells monolayer were evaluated by transepithelial electrical resistance (TEER), apparent permeability (Papp) of lucifer yellow, the activity of alkaline phosphatase (AKP), and microvilli morphology and tight junction structure under transmission electron microscope. Then, the Papp of rhodamine 123 (Rh123), a kind of P-gp specific substrate, was detected and the efflux rate was calculated. The Caco-2 cell monolayer, culturing at plastic flasks, was incubated for 72 h in 1% oxygen concentration, the expression level of P-gp was detected.@*RESULTS@#P-gp was decreased in Caco-2 cells with 1% oxygen concentration, especially the duration of 72 h (P<0.01). In hypoxic group, the TEER of monolayer was more than 400 Ω·cm2, the Papp of lucifer yellow was less than 5×10-7 cm/s, and the ratio of AKP activity between apical side and basal side was greater than 3. The establishment of Caco-2 monolayer model was successful, and hypoxia treatment did not affect the integrity and polarization state of the model. Compared with the normoxic control group, the efflux rate of Rh123 was significantly reduced in Caco-2 cell monolayer of the hypoxic group (P<0.01). Hypoxia reduced the expression of P-gp in Caco-2 cell monolayer (P<0.01).@*CONCLUSIONS@#Hypoxia inhibits P-gp function in Caco-2 cells, which may be related to the decreased P-gp level.
Subject(s)
Humans , ATP Binding Cassette Transporter, Subfamily B, Member 1 , Caco-2 Cells , ATP Binding Cassette Transporter, Subfamily B , Hypoxia , OxygenABSTRACT
Introdução: A inflamação é um fator presente na fisiopatologia de doenças, e, o intestino, órgão susceptível a disfunções e à disbiose, que está em constante exposição a microrganismos, pode estar associado a este processo. Por outro lado, aminoácidos de cadeia ramificada (ACR) podem apresentar efeitos anti-inflamatórios em linhagem celular intestinal. Objetivo: Investigar os efeitos da suplementação de ACR, in vitro, na modulação da resposta inflamatória e do estresse oxidativo induzida por LPS em modelo de células intestinais Caco-2. Métodos: As culturas de células foram distribuídas em seis grupos, sendo: dois grupos controle - controle com meio Dulbecco's Modified Eagle's Medium sem ACR (CTL0) e com ACR (CTL) - e quatro grupos suplementados - grupo leucina (LEU), grupo isoleucina (ISO), grupo valina (VAL) e associação de ACR (LIV). Foi adotado um protocolo de pré-tratamento, com os ACR e o LPS. A viabilidade celular foi avaliada pelo ensaio de redução do MTT (brometo de [3-(4,5-dimetiltiazol-2yl 2,5-difenil tetrazolium]). A análise de proteínas (mTOR, AKT, AMPK, NF-kB, TAK-1 e JNK) foi feita por Western Blotting. A dosagem de citocina IL-8 no sobrenadante de cultura celular foi realizada por meio do kit Multiplex para imunoensaio. Foram avaliados componentes do sistema antioxidante relacionado à glutationa (GSH, GSSG e GPx) por meio de kit comercial. Os resultados foram expressos como média ± erro padrão. Resultados: No teste de viabilidade celular por MTT, verificou-se que os grupos tratados com ACR e LPS não apresentaram comprometimento da viabilidade celular em relação ao grupo CTL sem LPS. Os grupos CTL0, CTL, VAL e LIV, quando estimulados com LPS, apresentaram maior capacidade de síntese, in vitro, de IL-8, bem como maior fosforilação das proteínas JNK e NF-kB em relação aos seus respectivos grupos sem LPS. A suplementação. Todavia, as células estimuladas com LPS e suplementadas com leucina e isoleucina apresentaram capacidade de síntese, in vitro, de IL-8 e fosforilação das proteínas JNK e NF-kB que não diferiram significativamente das células suplementadas com esses aminoácidos e não estimuladas com LPS. A ausência de ACR (grupo CTL0) e a suplementação desses aminoácidos, in vitro, em células intestinais Caco-2, tratadas com ou sem LPS, não induziram alteração da atividade da enzima GPx e da razão intracelular GSH/GSSG. Conclusões: Os aminoácidos leucina e isoleucina apresentaram potencial efeito anti-inflamatório nas células Caco-2 por meio da modulação da fosforilação das proteínas JNK e NF-kB, cujo fato está associado à modulação da síntese, in vitro, de IL-8, a qual está envolvida na resposta inflamatória no intestino.
Introduction: Inflammation is a factor present in the pathophysiology of diseases, and the intestine, an organ susceptible to dysfunction and dysbiosis, which is constantly exposed to microorganisms, may be associated with this process. On the other hand, branched-chain amino acids (BCAAs) may have anti-inflammatory effects on intestinal cell lines. Objective: To investigate the effects of ACR supplementation, in vitro, on the modulation of inflammatory response and oxidative stress induced by LPS in a model of intestinal Caco-2 cells. Methods: The cell cultures were divided into six groups, as follows: two control groups - control with Dulbecco's Modified Eagle's Medium without ACR (CTL0) and with ACR (CTL) - and four supplemented groups - leucine group (LEU), isoleucine group (ISO), valine group (VAL) and ACR association (LIV). A pre-treatment protocol was adopted, with ACR and LPS. Cell viability was assessed by MTT reduction assay ([3-(4,5-dimethylthiazol-2yl 2,5-diphenyl tetrazolium] bromide)) Protein analysis (mTOR, AKT, AMPK, NF-kB, TAK -1 and JNK) was performed by Western Blotting. The dosage of cytokine IL-8 in the cell culture supernatant was performed using the Multiplex kit for immunoassay. Components of the antioxidant system related to glutathione (GSH, GSSG, and GPx) were evaluated by commercial kit. The results were expressed as mean ± standard error. Results: In the cell viability test by MTT, it was verified that the groups treated with ACR and LPS did not show impairment of cell viability compared to the CTL group without LPS. The CTL0, CTL, VAL, and LIV groups, when stimulated with LPS, showed a greater capacity for in vitro synthesis of IL-8, as well as greater phosphorylation of JNK and NF-kB proteins in relation to their respective groups without LPS. However, cells stimulated with LPS and supplemented with leucine and isoleucine showed in vitro synthesis capacity of IL-8 and phosphorylation of JNK and NF-kB proteins that did not differ significantly from cells supplemented with these amino acids and not stimulated with LPS. The absence of ACR (CTL0 group) and the supplementation of these amino acids, in vitro, in intestinal Caco-2 cells, treated with or without LPS, did not induce changes in the activity of the GPx enzyme and the intracellular GSH/GSSG ratio. Conclusions: The amino acids leucine and isoleucine had a potential anti-inflammatory effect on Caco-2 cells by modulating the phosphorylation of JNK and NF-kB proteins, which fact is associated with the modulation of the in vitro synthesis of IL-8, which is involved in the inflammatory response in the gut.
Subject(s)
Lipopolysaccharides , Caco-2 Cells , Amino Acids, Branched-Chain , Inflammation , Intestinal MucosaABSTRACT
Objective: To analyze the effects of spvD gene on invasion and intracellular proliferation of Caco-2 cells and in order to provide insight into the function of that gene and the underlying mechanism of Salmonella caused infection. Methods: Functional verification of spvD gene deletion mutant and compensation strain. The deletion mutant strain was constructed through a suicide plasmid-mediated homologous recombination. The compensation plasmid constructed by cloning the coding sequence of spvD by PCR into plasmid pBAD33 was mobilized into the deletion mutant by conjugation and the pBAD33 was introduced into wild strains and deleted mutant strains as control. The relative expression of spvD mRNA was detected by quantitative reverse transcription PCR. In order to analyze the virulence of spvD against Caco-2 cells, Caco-2 cells was cocultured with wild type Salmonella enteritidis carrying spvD gene, the deletion mutant strain and compensation strain respectively. The expression level of spvD mRNA and the the number of Salmonella enteritidis after Caco-2 cells intervention were compared between the three groups by LSD-t test, and the invasion rate was compared by χ2 test. Results: The expression level of spvD mRNA in wild type Salmonella enteritidis was set as unit "1", the deletion mutant strain was "0.00", and the compensation strain was "2.60" (LSD-twild, deleted=1.11, P=0.31; LSD-twild, compensation=-1.77, P=0.13; LSD-t deleted, compensation=-2.88, P=0.03), which confirmed the successful construction of the deletion mutant strain and the compensation strain. The invasion experiment results of the above three Salmonella enteritidis strains on Caco-2 cells showed that the invasion rate of wild strain was 0.23%, the invasion rate of deleted mutant strain was 0.16%, and the invasion rate of compensation strain was 0.16%, with no statistical significance (χ2=1.13, P=0.570). By comparing the number of Salmonella enteritidis at different time points after Caco-2 cells intervention, it was discovered that the number of Salmonella enteritidis in wild strains (6.50×106 CFU/ml) and compensation strains (7.25×106 CFU/ml) was significantly increased than that in deletion mutant strain (1.90×106 CFU/ml) after 16 h coculture (LSD-twild, deleted=7.95, P=0.00; LSD-twild, compensation=-1.27, P=0.25; LSD-t deleted, compensation=-9.22, P=0.00). Conclusion: It is not considered that spvD gene can affect the invasion of Salmonella enteritidis on Caco-2 cells, but the gene can promote the reproduction of Salmonella enteritidis in Caco-2 cells.
Subject(s)
Humans , Caco-2 Cells , Gene Deletion , Lysergic Acid Diethylamide , RNA, Messenger/genetics , Salmonella enteritidis/geneticsABSTRACT
Objective: Comparative analyses of wild-type Clostridioides difficile 630 (Cd630) strain and pathogenicity locus (PaLoc) knockout mutant (ΔPaLoc) by using RNA-seq technology. Analysis of differential expression of Cd630 wild-type strain and ΔPaLoc mutant strain and measurement of its cellular virulence changes. Lay the foundation for the construction of an toxin-attenuated vaccine strain against Clostridioides difficile. Methods: Analysis of Cd630 and ΔPaLoc mutant strains using high-throughput sequencing (RNA-seq). Clustering differentially expressed genes and screening differentially expressed genes by DESeq software. Further analysis of differential genes using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment. Finally, cytotoxicity assays of ΔPaLoc and Cd630 strains were performed in the African monkey kidney epithelial cell (Vero) and the human colonic cell (Caco-2) lines. Results: The transcriptome data showed that the ΔPaLoc mutant toxin genes tcdA and tcdB were not transcribed. Compared to the wild-type strain, CD630_36010, CD630_020910,CD630_02080 and cel genes upregulated 17.92,11.40,8.93 and 7.55 fold, respectively. Whereas the hom2 (high serine dehydrogenase), the CD630_15810 (spore-forming protein), CD630_23230 (zinc-binding dehydrogenase) and CD630_23240 (galactitol 1-phosphate 5-dehydrogenase) genes were down-regulated by 0.06, 0.075, 0.133 and 0.183 fold, respectively. The GO and KEGG enrichment analyses showed that the differentially transcribed genes in ΔPaLoc were enriched in the density-sensing system, ABC transport system, two-component system, phosphotransferase (PTS) system, and sugar metabolism pathway, as well as vancomycin resistance-related pathways. Cytotoxicity assays showed that the ΔPaLoc mutant strain lost its virulence to Vero and Caco-2 cells compared to the wild-type Cd630 strain. Conclusion: Transcriptional sequencing analysis of the Cd630 and ΔPaLoc mutant strains showed that the toxin genes were not transcribed. Those other differential genes could provide a reference for further studies on the physiological and biochemical properties of the ΔPaLoc mutant strain. Cytotoxicity assays confirmed that the ΔPaLoc mutant lost virulence to Vero and Caco-2 cells, thus laying the foundation for constructing an toxin-attenuated vaccine strain against C. difficile.
Subject(s)
Humans , Bacterial Proteins/metabolism , Bacterial Toxins/metabolism , Caco-2 Cells , Clostridioides , Clostridioides difficile/genetics , Oxidoreductases/metabolism , Transcriptome , Vaccines, AttenuatedABSTRACT
L-Asparaginase catalysing the breakdown of L-Asparagine to L-Aspartate and ammonia is an enzyme of therapeutic importance in the treatment of cancer, especially the lymphomas and leukaemia. The present study describes the recombinant production, properties and anticancer potential of enzyme from a hyperthermophilic archaeon Pyrococcus abyssi. There are two genes coding for asparaginase in the genome of this organism. A 918 bp gene encoding 305 amino acids was PCR amplified and cloned in BL21 (DE3) strain of E. coli using pET28a (+) plasmid. The production of recombinant enzyme was induced under 0.5mM IPTG, purified by selective heat denaturation and ion exchange chromatography. Purified enzyme was analyzed for kinetics, in silico structure and anticancer properties. The recombinant enzyme has shown a molecular weight of 33 kDa, specific activity of 1175 U/mg, KM value 2.05mM, optimum temperature and pH 80°C and 8 respectively. No detectable enzyme activity found when L-Glutamine was used as the substrate. In silico studies have shown that the enzyme exists as a homodimer having Arg11, Ala87, Thr110, His112, Gln142, Leu172, and Lys232 being the putative active site residues. The free energy change calculated by molecular docking studies of enzyme and substrate was found as ∆G 4.5 kJ/mole indicating the affinity of enzyme with the substrate. IC50 values of 5U/mL to 7.5U/mL were determined for FB, caco2 cells and HepG2 cells. A calculated amount of enzyme (5U/mL) exhibited 78% to 55% growth inhibition of caco2 and HepG2 cells. In conclusion, the recombinant enzyme produced and characterized in the present study offers a good candidate for the treatment of cancer. The procedures adopted in the present study can be prolonged for in vivo studies.
A L-asparaginase, que catalisa a degradação da L-asparagina em L-aspartato e amônia, é uma enzima de importância terapêutica no tratamento do câncer, especialmente dos linfomas e da leucemia. O presente estudo descreve a produção recombinante, propriedades e potencial anticancerígeno da enzima de Pyrococcus abyssi, um archaeon hipertermofílico. Existem dois genes que codificam para a asparaginase no genoma desse organismo. Um gene de 918 bp, que codifica 305 aminoácidos, foi amplificado por PCR e clonado na cepa BL21 (DE3) de E. coli usando o plasmídeo pET28a (+). A produção da enzima recombinante foi induzida sob 0,5mM de IPTG, purificada por desnaturação seletiva por calor e cromatografia de troca iônica. A enzima purificada foi analisada quanto à cinética, estrutura in silico e propriedades anticancerígenas. A enzima recombinante apresentou peso molecular de 33 kDa, atividade específica de 1.175 U / mg, valor de KM 2,05 mM, temperatura ótima de 80º C e pH 8. Nenhuma atividade enzimática detectável foi encontrada quando a L-glutamina foi usada como substrato. Estudos in silico mostraram que a enzima existe como um homodímero, com Arg11, Ala87, Thr110, His112, Gln142, Leu172 e Lys232 sendo os resíduos do local ativo putativo. A mudança de energia livre calculada por estudos de docking molecular da enzima e do substrato foi encontrada como ∆G 4,5 kJ / mol, indicando a afinidade da enzima com o substrato. Valores de IC50 de 5U / mL a 7,5U / mL foram determinados para células FB, células caco2 e células HepG2. Uma quantidade de enzima (5U / mL) apresentou inibição de crescimento de 78% a 55% das células caco2 e HepG2, respectivamente. Em conclusão, a enzima recombinante produzida e caracterizada no presente estudo é uma boa possibilidade para o tratamento do câncer. Os procedimentos adotados na presente pesquisa podem ser aplicados para estudos in vivo.
Subject(s)
Humans , Asparaginase/biosynthesis , Asparaginase/pharmacology , Pyrococcus abyssi/enzymology , Antineoplastic Agents/pharmacology , Substrate Specificity , Enzyme Stability , Recombinant Proteins/biosynthesis , Recombinant Proteins/pharmacology , Caco-2 Cells , Escherichia coli/genetics , Molecular Docking Simulation , Hydrogen-Ion ConcentrationABSTRACT
BACKGROUND: Butyrate is a histone deacetylase inhibitor that induces apoptosis and inhibits cell proliferation of colorectal cancer cells. To improve its anticancer activity, butyrate has been evaluated mixed with drugs and different molecules. Plant antimicrobial peptides are attractive anticancer alternative molecules because they show selective cytotoxic activity against different cancer cell lines. In this work, we explore if the plant defensin c-thionin (Capsicum chinense) can improve butyrate activity on Caco-2 cell line and we also determined the mechanism of death activated. RESULTS: The combined treatment of c-thionin (3.5 mM) and butyrate (50 mM) showed higher cytotoxicity on Caco-2 cells with respect to single treatments. Also, the combined treatment reduced cell proliferation and exhibited a higher rate of apoptosis than single treatments. Combined treatment induced caspases 8 and 9 activation to an extent comparable with that of butyrate while c-thionin did not activate caspases. Additionally, reactive oxygen species generation preceded the onset of apoptosis, and superoxide anion production was higher in cells treated with the combined treatment. CONCLUSIONS: The c-thionin from Habanero chili pepper improved the butyrate cytotoxicity on Caco-2 cells. This effect occurred through apoptosis induction associated with reactive oxygen species production. Therefore, the combination of butyrate with cytotoxic antimicrobial peptides could be an attractive strategy for cancer therapy.
Subject(s)
Humans , Butyrates , Capsicum/chemistry , Adenocarcinoma , Colonic Neoplasms , Cell Cycle , Reactive Oxygen Species , Apoptosis , Caco-2 Cells , Defensins , ThioninsABSTRACT
To investigate the effect and mechanism of metformin on intestinal epithelial barrier injury in ulcerative colitis. A cell model of colitis was established by co-culture of human colon cancer cell line Caco-2 and human monocyte cell line THP-1. The colitis model cells were treated with metformin at concentration of for Flow cytometry was used to detect Caco-2 cell apoptosis, and Western blotting was used to detect the protein expression of tight junction proteins and endoplasmic reticulum stress-related proteins. After metformin treatment, the apoptosis rate of Caco-2 cells was decreased from (14.22±2.34)% to 0.61)% (=3.119, <0.05), and the expression levels of tight junction protein-1 and claudin-1 increased (=5.172 and 3.546, both <0.05). In addition, the expression levels of endoplasmic reticulum-related proteins glucose regulated protein (GRP) 78, C/EBP homologous protein (CHOP) and caspase-12, as well as the phosphorylation level of PRKR-like endoplasmic reticulum kinase (PERK) and eukaryotic translation initiation factor 2α (eIF2α) decreased (all <0.05). Metformin may alleviate the intestinal epithelial barrier damage in colitis by reducing intestinal epithelial cell apoptosis and increasing the expression of tight junction proteins, which may be associated with the inhibition of endoplasmic reticulum stress-induced apoptotic pathway.
Subject(s)
Humans , Apoptosis , Caco-2 Cells , Colitis, Ulcerative , Endoplasmic Reticulum Stress , Metformin/pharmacologyABSTRACT
In this study, we studied the solubility and permeability of matrine, oxymatrine, sophoridine, and oxysophocarpine, four alkaloids in the Mongolian herbal medicine Sophorae Flavescentis Radix, and evaluated the absorption mechanism with the Caco-2 cell model, so as to provide a basis for the new drug development and efficacy evaluation of Sophorae Flavescentis Radix. The results showed that all the four alkaloids had high solubility and high permeability and can be well absorbed, belonging to the class-I drugs of Biopharmaceutical Classification System(BCS). The absorption(AP→BL) and excretion(BL→AP) of matrine and oxymatrine were not affected by the concentration while the absorption depended on P-gp protein. The absorption(AP→BL) and excretion(BL→AP) of sophoridine and oxysophocarpine were positively related to the concentration and time, and the absorption process was independent from P-gp protein. The results provide scientific reference and an experimental basis for the development of Mongolian medical prescriptions containing Sophorae Flavescentis Radix.
Subject(s)
Humans , Alkaloids , Biological Products , Caco-2 Cells , Drugs, Chinese Herbal , Herbal Medicine , SophoraABSTRACT
This study was designed to evaluate the role of short-chain fatty acid butyrate acid on intestinal morphology and function, and atherosclerotic plaque formation in apolipoprotein E-knockout (ApoE
Subject(s)
Animals , Humans , Mice , Apolipoproteins E/genetics , Atherosclerosis/prevention & control , Butyrates/pharmacology , Caco-2 Cells , Diet, High-Fat/adverse effects , Fatty Acids, Volatile , Mice, Inbred C57BL , Mice, Knockout , Plaque, AtheroscleroticABSTRACT
Network pharmacology and liver fibrosis(LF) model in vitro were used to analyze the underly mechanism of anti-liver fibrosis effect that induced by Piperis Longi Fructus and its major active compounds. TCMSP and TCMIP were used to search for the chemical constituents of Piperis Longi Fructus, as well as the oral bioavailability(OB), drug-likeness(DL), intercellular permeability of intestinal epithelial cells(Caco-2) and Drug-likeness grading were set as limiting conditions. The related target genes of Piperis Longi Fructus were queried by TCMSP database, while related targets of LF were screened by GeneCards databases. Interaction network was constructed using Cytoscape 3.7.1. These above data were imported into STRING database for PPI network analysis. Enrichment of gene ontology(GO) and pathway analysis(KEGG) within Bioconductor database were utilized to note functions of related targets of Piperis Longi Fructus. Finally, the core targets and pathways were preliminarily verified by in vitro experiments. The effects of piperlongumine(PL), the major active component of Piperis Longi Fructus, on proliferation of rat liver stellate cells(HSC-T6) and expression of α smooth muscle actin(α-SMA) and collagen Ⅰ were investigated. The major factors TNF-α of tumor necrosis factor(TNF) pathway and NF-κB p65, IL-6 protein expressions of LF process were examined. A total of 12 active compounds such as PL were obtained by analyzing the bioavailability and drug-like properties, which inferred to 48 targets. The functional enrichment analysis of GO obtained 1 240 GO items, mainly involving in process of biology and molecular function. A total of 99 signaling pathways were enriched in the KEGG pathway enrichment analysis, including TNF signaling pathway, cGMP-PKG signaling pathway, calcium signaling pathways. CCK-8 assay showed that PL inhibited proliferation of HSC-T6 induced by transforming growth factor-β1(TGF-β1). Western blot analysis found that treated with PL suppressed the protein expressions of α-SMA, collagen Ⅰ, TNF-α and p65 in HSC-T6. Enzyme linked immunosorbent assay(ELISA) showed that PL inhibited the expressions of TNF-α and IL-6 in the cluture supertant of HSC-T6 cells. In conclusion, PL could play an anti-liver fibrosis role by regulating TNF/NF-κB signaling pathway. This study provided the mechanism basis of anti-LF effects induced by Piperis Longi Fructus and its major active compounds, which might help for the further study of the mechanism and key targets of Piperis Longi Fructus.
Subject(s)
Animals , Humans , Rats , Caco-2 Cells , Hepatic Stellate Cells/metabolism , Liver Cirrhosis/genetics , NF-kappa B/metabolism , Signal TransductionABSTRACT
To evaluate the effects of Hydroxypropyl methylcellulose acetate succinate(HPMCAS MF) on absorption of silybin(SLB) from supersaturable self-nanoemulsifying drug delivery system which was pre-prepared at the early stage experiment. The cell toxicity of self-emulsifying preparation was evaluated by the MTT method, and the in vitro membrane permeability and absorption promoting effect of the self-emulsifying preparation were evaluated by establishing a Caco-2 cell monolayer model. The in vivo and in vitro supersaturation correlation was evaluated via the blood concentration of SLB. The results of MTT showed that the concentration of the preparation below 2 mg·mL~(-1)(C_(SLB) 100 μg·mL~(-1)) was not toxic to Caco-2 cells, and the addition of polymer had no significant effect on Caco-2 cells viability. As compared with the solution group, the transport results showed that the P_(app)(AP→BL) of the self-emulsifying preparation had a very significant increase; the transport rate of silybin can be reduced by polymer in 0-30 min; however, there was no difference in supersaturated transport between supersaturated SLB self-nanoemulsion drug delivery system(SLB-SSNEDDS) and SLB self-nanoemulsion drug delivery system(SLB-SNEDDS) within 2 hours. As compared with SLB suspension, pharmacokinetic parameters showed that the blood concentration of both SLB-SNEDDS and SLB-SSNEDDS groups were significantly increased, and C_(max) was 5.25 times and 9.69 times respectively of that in SLB suspension group, with a relative bioavailability of 578.45% and 1 139.44% respectively. C_(max) and relative bioavailability of SLB-SSNEDDS were 1.85 times and 197% of those of SLB-SNEDDS, respectively. Therefore, on the one hand, SSNEDDS can increase the solubility of SLB in gastrointestinal tract by maintaining stability of SLB supersaturation state; on the other hand, the osmotic transport process of SLB was regulated through the composition of its preparations, and both of them could jointly promote the transport and absorption of SLB to improve the oral bioavailability of SLB.
Subject(s)
Humans , Administration, Oral , Biological Availability , Caco-2 Cells , Drug Delivery Systems , Emulsions , Methylcellulose/analogs & derivatives , Nanoparticles , Particle Size , Silymarin , SolubilityABSTRACT
Nanocrystals self-stabilized Pickering emulsion(NSSPE) is a new kind of emulsion where only nanocrystals of poorly soluble drugs are used as stabilizers. Our previous study showed that NSSPE with Ligusticum chuanxiong oil as the main oil phase can significantly promote oral absorption of puerarin. The present study aimed to explore its absorption mechanism in oral administration. The in vitro dissolution test was carried out to study the effect of NSSPE on release of puerarin. The effects and mechanism of NSSPE on uptake and transport of puerarin across Caco-2 cell were investigated. The results showed that the drug release rate of NSSPE was similar to that of nanocrystals, with their cumulative dissolution of puerarin not affected by pH of releasing mediums, both significantly higher than that of crude material. The uptake of puerarin in NSSPE was concentration-dependent and significantly higher than that of solution or surfactant stabilized emulsion. Genistein and indomethacin, inhibitors of lipid rafts/caveolin, could significantly reduce the uptake of puerarin in NSSPE. Compared with solution, NSSPE and surfactants stabilized emulsion obviously increased transport rate K_a and apparent permeability coefficient P_(app) of puerarin in AP → BL direction, but there was no significant difference in BL → AP direction. It could be inferred that there were both passive and active transport mechanisms, as well as lipid raft/caveolin mediated endocytosis for absorption of NSSPE. The promoted oral absorption of puerarin in NSSPE was mainly related to the existing nanocrystal form which could promote dissolution, puerarin as well as Ligusticum chuanxiong oil which could promote drug transmembrane transport and inhibit drug efflux. It is the unique structure and composition of the compound NSSPE that promoted the oral absorption of puerarin.
Subject(s)
Humans , Caco-2 Cells , Drugs, Chinese Herbal , Emulsions , Isoflavones , NanoparticlesABSTRACT
The absorption is the key to the resulted efficacy of orally administered drugs and the small intestine is the main site to absorb the orally administered drug. In this paper, internationally recognized human colon adenocarcinoma cell line(Caco-2) monola-yer model which can simulate small intestinal epithelial cell was used to comparatively study the absorption and transportation diffe-rences of total coumarins and main individual coumarin in Angelica dahurica 'Yubaizhi' by separately using 6-and 12-well plates. It was found that apparent permeability coefficient(P_(app)) values of oxypeucedanin hydrate, byakangelicin and phellopterin were at the quantitative degree of 1 × 10~(-5) cm·s~(-1) when the individual administration was conducted independently, indicating that they were well-absorbed compounds. P_(app) ratio of their bi-directional transportation was close to 1, indicating that they can be absorbed across Caco-2 monolayer by passive diffusion mechanism without carrier mediation during the transportation. The similar trend of transportation was also observed for imperatorin, isoimperatorin and bergapten. The P_(app) values of oxypeucedanin hydrate, byakangelicin and bergapten were at quantitative degree of 1 × 10~(-5) cm·s~(-1) when the administration of total coumarins in Angelica dahurica 'Yubaizhi' was conducted, indicating that they were well-absorbed compounds. The results were consistent with those of independent administration of individual coumarins. Whereas, the P_(app) values of imperatorin, phellopterin and isoimperatorin in the total coumarins decreased, indicating that the interaction between compounds may exist although the P_(app) value ratio of bi-directional transportation was between 0.5 and 1.5. The results laid the foundation for intestinal absorption study of Angelica dahurica 'Yubaizhi' coumarins in compound Chinese medicine.
Subject(s)
Humans , Angelica , Caco-2 Cells , Coumarins , Drugs, Chinese Herbal , Intestinal Absorption , Plant RootsABSTRACT
Aims@#Lactococcus lactis is a non-colonizing, generally-regarded as safe (GRAS) lactic acid bacteria that has been frequently studied as a potential vector for bactofection. To mediate bactofection, a series of interaction between the bacteria and the host cell needs to occur. This study aims to investigate the in vitro bacterial-cell interaction between a locally-isolated L. lactis M4 strain with human colorectal cancer line, Caco-2.@*Methodology and results@#Bacterial interaction was evaluated via adherence and internalisation assays. A 250:1 ratio of bacteria to cancer cell was selected as the optimum multiplicity of infection for all assays. After 2 h, L. lactis M4 was able to adhere to and internalise into Caco-2 cells at comparable rates to commercial strains L. lactis NZ9000 and MG1363. @*Conclusion, significance and impact of study@#Findings from this study showed that this strain has similar interaction properties with the commercial strains and would make a promising candidate for future bactofection studies and development of bacteria-mediated DNA vaccination against various diseases.
Subject(s)
Lactococcus lactis , Colorectal Neoplasms , Caco-2 CellsABSTRACT
Introdução - O risco de doenças cardiovasculares, dentre elas a aterosclerose, está associado com a hipercolesterolemia, resultado de fatores de risco comportamentais, metabólicos e genéticos. Intervenções dietéticas como o uso do guaraná (Paullinia cupana), podem ser úteis, uma vez que é um alimento rico em compostos bioativos como as catequinas, que possuem elevada atividade antioxidante, inibem a oxidação da lipoproteína de densidade baixa (LDL) e a peroxidação lipídica, sendo capazes de reduzir a concentração plasmática de colesterol, por mecanismos ainda não totalmente elucidados. Objetivo - Investigar os efeitos do extrato aquoso de guaraná (Paullinia cupana) em pó sobre mecanismos envolvidos com a absorção de colesterol em modelos in vitro e em células Caco-2. Métodos - O extrato aquoso do guaraná em pó foi submetido à digestão in vitro, os fenólicos totais foram quantificados pelo método de Folin-Ciocalteu e a determinação do perfil de fenólicos foi realizada por cromatografia líquida de alta eficiência (HPLC), com detector UV/VIS a 210 nm. A atividade antioxidante foi determinada pela capacidade de absorbância de radical oxigênio (Oxygen Radical Absorbance Capacity - ORAC) e foram avaliadas a capacidade de inibição da lipase pancreática, de ligação com ácidos biliares, de interação com a fosfatidilcolina micelar e de inibição da solubilização micelar do colesterol de forma in vitro. Foi realizado ensaio de permeação do colesterol por um período de 2 h em células Caco-2 semeadas e diferenciadas em placas transwell de 24 poços com uma solução de micelas de colesterol e extrato de guaraná em diferentes concentrações. O teor de colesterol permeado foi determinado por HPLC/UV a 206 nm. Foi realizado o ensaio de Western blotting para determinar o conteúdo proteico dos transportadores de colesterol (NPC1L1, ABCG5, ABCG8) e LXR-alfa em células intestinais Caco-2 após a incubação com diferentes concentrações do extrato em 2 e 16 horas. Resultados: O conteúdo total de fenólicos do extrato de guaraná foi 104,36 (± 3,62) mg EAG/g de guaraná em pó. Após o processo de digestão, este valor foi de 48,62 (± 3,97) mg EAG/g de guaraná em pó, demonstrando a bioacessibilidade dos polifenóis. Foram identificados os compostos procianidina B1 (1,56 ± 0,04 mg/g) e B2 (2,34 ± 0,06 mg/g), catequina (24,26 ± 0,63 mg/g), epicatequina (20,39 ± 1,20 mg/g) e cafeína (34,93 ± 0,75 mg/g) no extrato não digerido. Após digestão in vitro, somente a catequina, epicatequina e cafeína foram bioacessíveis com 181,16 %, 136,78 % e 213,51 % de bioacessibilidade, respectivamente. A atividade antioxidante do extrato aquoso não digerido foi menor que do digerido, sendo os valores finais de ORAC de 2512 (± 399) e 4321 (± 778) µmol Eq Trolox/g de guaraná em pó, respectivamente. O extrato exibiu uma atividade inibitória da enzima lipase pancreática de forma dose-dependente, com IC50 de 1033 µg/mL. O extrato também demonstrou uma capacidade de ligação ao taurocolato de sódio de 45,63 (± 8,50) % e de 44,30 (± 8,88) % com concentrações de 1,0 mg/mL e 0,5 mg/mL, respectivamente, correspondendo a 71,78 (± 13,36) % e 93,11 (± 18,65) % da capacidade de ligação da colestiramina quando utilizada nas mesmas concentrações. Observou-se uma redução de 20,47 (± 10,24) % e 17,06 (± 12,88) % na concentração da fosfatidilcolina micelar quando o guaraná foi utilizado nas concentrações de 1,0 e 0,50 mg/mL, respectivamente, em comparação com a micela padrão sem amostra e uma inibição da solubilização micelar do colesterol de 10,14 % pelo guaraná a 1,0 mg/mL. Após o experimento de permeação, as concentrações de colesterol no compartimento basolateral foram de 197,89 (± 3,95), 151,76 (± 1,39) e 94,51 (± 9,49) µg/mL, quando 0,025, 0,050 ou 0,075 mg/mL de guaraná foram utilizados, respectivamente, demonstrando redução de 23,31 % e 52,24 % à medida que a concentração de guaraná utilizada aumentou. Observou-se uma redução do conteúdo proteico do NPC1L1 após 16 horas de incubação com guaraná nas concentrações de 0,050 e 0,075 mg/mL. Em relação ao ABCG5, observou-se um aumento do conteúdo nas concentrações de 0,025 e 0,075 mg/mL de guaraná após 02 horas. Não foram observadas diferenças importantes nos conteúdos de ABCG8 e do LXR-alfa. Conclusões: O extrato aquoso de guaraná em pó demonstrou uma redução da absorção de colesterol em células Caco-2. O extrato também demonstrou uma atividade inibitória da lipase pancreática dose-dependente, uma boa capacidade de ligação aos ácidos biliares e de interação com a fosfatidilcolina micelar, além de uma capacidade de inibição da solubilização micelar do colesterol de forma in vitro. O extrato também foi capaz de modular negativamente o conteúdo proteico do NPC1L1 e positivamente o conteúdo do ABCG5. A sua ingestão pode ser considerada uma importante fonte alimentar com potencial efeito hipocolesterolêmico, capaz de reduzir a absorção de lipídios no intestino, podendo ser utilizado como adjuvante na regulação da hipercolesterolemia, provavelmente devido à presença de polifenóis.
Introduction - The risk of cardiovascular diseases, such as atherosclerosis, is associated with hypercholesterolemia, a result of behavioral and metabolic risk factors. Dietary interventions with the use of guarana (Paullinia cupana) may be useful, since it is a food rich in bioactive compounds such as catechins, which have high antioxidant activity, inhibit oxidation of LDLc and lipid peroxidation, being able to lower blood cholesterol levels, by mechanisms not yet fully elucidated. Objective - To investigate the effects of guarana (Paullinia cupana) powder aqueous extract on mechanisms involved with the absorption of cholesterol in vitro and in Caco-2 cells. Methods - The guarana powder aqueous extract was subjected to in vitro digestion, the total phenolics content were quantified by the Folin-Ciocalteu method and the determination of the phenolic profile was performed by high performance liquid chromatography (HPLC) UV/VIS at 210 nm. The antioxidant activity was determined by Oxygen Radical Absorbance Capacity (ORAC) and the ability to inhibit pancreatic lipase, to binding with bile acids, the interaction with micellar phosphatidylcholine and the inhibition of micellar solubilization of cholesterol in vitro were evaluated. Cholesterol permeation assay was performed for a period of 2 hours in Caco-2 cells seeded and differentiated in 24- transwell plates with a solution of cholesterol micelles and guarana extract at different concentrations. The permeated cholesterol content was determined by HPLC/UV at 206 nm. The Western blotting assay was performed to determine the protein content of cholesterol transporters (NPC1L1, ABCG5, ABCG8) and LXR-alpha in Caco-2 cells after incubation with different concentrations of the extract in 2 and 16 hours. Results: The total phenolic content of the guarana extract was 104.36 (± 3.62) mg EAG/g of guarana powder. After the digestion process, this value was 48.62 (± 3.97) mg EAG/g of guarana powder, demonstrating the bioaccessibility of the polyphenols. Procyanidin B1 (1.56 ± 0.04 mg/g) and B2 (2.34 ± 0.06 mg/g), catechin (24.26 ± 0.63 mg/g), epicatechin (20.39 ± 1.20 mg/g) and caffeine (34.93 ± 0.75 mg/g) were identified in the undigested extract. After in vitro digestion, only catechin, epicatechin and caffeine were bioaccessible with 181.16 %, 136.78 % and 213.51 % of bioaccessibility, respectively. The antioxidant activity of the undigested aqueous extract was lower than that digested, with the final ORAC values of 2512 (± 399) and 4321 (± 778) µmol Eq Trolox/g of guarana powder. The extract exhibited an inhibitory activity of the pancreatic lipase enzyme in a dose-dependent manner, with an IC50 of 1033 µg/mL. The extract also demonstrated a sodium taurocholate binding capacity of 45.63 (± 8.50) % and 44.30 (± 8.88) % with concentrations of 1.0 mg/mL and 0.5 mg/mL, respectively, corresponding to 71.78 (± 13.36)% and 93.11 (± 18.65)% of the cholestyramine binding capacity when used at the same concentrations. A reduction of 20.47 (± 10.24) % and 17.06 (± 12.88) % was observed in the concentration of micellar phosphatidylcholine when guarana was used at concentrations of 1.0 and 0.50 mg/mL, respectively, compared to the standard micelle without sample and an inhibition of 10.14 % micellar cholesterol solubilization by guarana at 1.0 mg/mL. After the permeation experiment, the cholesterol concentrations in the basolateral compartment were 197.89 (± 3.95), 151.76 (± 1.39) and 94.51 (± 9.49) µg/mL, when 0.025, 0.050 or 0.075 mg/mL of guarana were used, respectively, showing a reduction of 23.31 % and 52.24 % as the concentration of guarana used increased. A reduction in the protein content of NPC1L1 was observed after 16 hours of incubation with guarana at concentrations of 0.050 and 0.075 mg/mL. After 02 hours, an increase in the content of ABCG5 at concentrations of 0.025 and 0.075 mg/mL of guarana was observed. No significant differences were observed in the contents of ABCG8 and LXR-α. Conclusions: The aqueous extract of guarana powder showed a reduction in the absorption of cholesterol in Caco-2 cells. The extract also demonstrated a dose-dependent pancreatic lipase inhibitory activity, a good ability to bind bile acids and to interact with micellar phosphatidylcholine, in addition to an ability to inhibit micellar solubilization of cholesterol in vitro. The extract was also able to negatively modulate the protein content of NPC1L1 and positively the content of ABCG5. Its intake can be considered an important dietary source with a potential hypocholesterolemic effect, capable of reducing the absorption of lipids in the intestine, and can be used as an adjunct in the control of hypercholesterolemia, probably due to the presence of polyphenols.
Subject(s)
Cholesterol , Caco-2 Cells , Paullinia , Polyphenols , Cardiovascular Diseases , HypercholesterolemiaABSTRACT
BACKGROUND: Mast cells (MCs) have been found to play a critical role during development of inflammatory bowel disease (IBD) that characterized by dysregulation of inflammation and impaired intestinal barrier function. However, the function of MCs in IBD remains to be fully elucidated. RESULTS: In our study, we used exosomes isolated from human mast cells-1 (HMCs-1) to culture with NCM460, HT-29 or CaCO2 of intestinal epithelial cells (lECs) to investigate the communication between MCs and lECs. We found that MCs-derived exosomes significantly increased intestinal epithelial permeability and destroyed intestinal barrier function, which is attributed to exosome-mediated functional miRNAs were transferred from HMCs-1 into lECs, leading to inhibit tight junction-related proteins expression, including tight junction proteins 1 (TJP1, ZO-1), Occludin (OCLN), Claudin 8 (CLDN8). Microarray and bioinformatic analysis have further revealed that a panel of miRNAs target different tight junction-related proteins. Interestingly, miR-223 is enriched in mast cell-derived exosome, which inhibit CLDN8 expression in IECs, while treatment with miR-223 inhibitor in HT-29 cells significantly reversed the inhibitory effect of HMCs-1-derived exosomes on CLDN 8 expression. Most importantly, enrichment of MCs accumulation in intestinal mucosa of patients with IBD compared with those healthy control. CONCLUSIONS: These results indicated that enrichment of exosomal miR-223 from HMCs-1 inhibited CLDN8 expression, leading to destroy intestinal barrier function. These finding provided a novel insight of MCs as a new target for therapeutic treatment of IBD.